NO20022113L - Bruk av nitrogenoksid for behandling av sammensnöringer i luftveiene - Google Patents

Bruk av nitrogenoksid for behandling av sammensnöringer i luftveiene

Info

Publication number
NO20022113L
NO20022113L NO20022113A NO20022113A NO20022113L NO 20022113 L NO20022113 L NO 20022113L NO 20022113 A NO20022113 A NO 20022113A NO 20022113 A NO20022113 A NO 20022113A NO 20022113 L NO20022113 L NO 20022113L
Authority
NO
Norway
Prior art keywords
constriction
treatment
nitric oxide
respiratory tract
respiratory
Prior art date
Application number
NO20022113A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022113D0 (no
Inventor
Josephine Hjoberg
Goeran Hedenstierna
Marieann Hoegmann
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Publication of NO20022113D0 publication Critical patent/NO20022113D0/no
Publication of NO20022113L publication Critical patent/NO20022113L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20022113A 1999-11-03 2002-05-02 Bruk av nitrogenoksid for behandling av sammensnöringer i luftveiene NO20022113L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide
PCT/SE2000/002153 WO2001032202A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction

Publications (2)

Publication Number Publication Date
NO20022113D0 NO20022113D0 (no) 2002-05-02
NO20022113L true NO20022113L (no) 2002-05-02

Family

ID=20417596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022113A NO20022113L (no) 1999-11-03 2002-05-02 Bruk av nitrogenoksid for behandling av sammensnöringer i luftveiene

Country Status (20)

Country Link
EP (1) EP1225913B8 (de)
JP (1) JP2003513048A (de)
CN (1) CN1230199C (de)
AR (1) AR026335A1 (de)
AT (1) ATE302023T1 (de)
AU (1) AU778347B2 (de)
BR (1) BR0015329A (de)
CA (1) CA2389655A1 (de)
CZ (1) CZ20021559A3 (de)
DE (1) DE60022070T2 (de)
EE (1) EE200200240A (de)
ES (1) ES2248153T3 (de)
HU (1) HUP0203065A3 (de)
IL (1) IL149170A0 (de)
MX (1) MXPA02004069A (de)
NO (1) NO20022113L (de)
PL (1) PL354653A1 (de)
SE (1) SE9903985D0 (de)
WO (1) WO2001032202A1 (de)
ZA (1) ZA200203391B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
US7378438B2 (en) 2002-04-19 2008-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
CA2490392A1 (en) * 2002-06-21 2003-12-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
EP2359845A4 (de) * 2008-12-03 2015-05-27 Ltt Bio Pharma Co Ltd Inhalat mit modifzierter superoxid-dismutase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000103I1 (de) * 1990-12-05 2008-04-03 Gen Hospital Corp Verwendung von NO zur Behandlung der persistenten pulmonalen Hypertonie des Neugeborenen
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
AU6031096A (en) * 1995-06-05 1996-12-24 Duke University Nitrosylated and nitrated superoxide oxidants and reductants
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds

Also Published As

Publication number Publication date
NO20022113D0 (no) 2002-05-02
JP2003513048A (ja) 2003-04-08
CZ20021559A3 (cs) 2003-05-14
EP1225913B8 (de) 2005-10-19
AU778347B2 (en) 2004-12-02
DE60022070T2 (de) 2006-03-30
CN1387441A (zh) 2002-12-25
HUP0203065A3 (en) 2006-07-28
AR026335A1 (es) 2003-02-05
CA2389655A1 (en) 2001-05-10
BR0015329A (pt) 2002-07-09
EP1225913B1 (de) 2005-08-17
AU1745601A (en) 2001-05-14
DE60022070D1 (de) 2005-09-22
ATE302023T1 (de) 2005-09-15
ZA200203391B (en) 2002-12-20
HUP0203065A2 (hu) 2003-01-28
CN1230199C (zh) 2005-12-07
SE9903985D0 (sv) 1999-11-03
ES2248153T3 (es) 2006-03-16
WO2001032202A1 (en) 2001-05-10
MXPA02004069A (es) 2003-08-20
IL149170A0 (en) 2002-11-10
PL354653A1 (en) 2004-02-09
EE200200240A (et) 2003-06-16
EP1225913A1 (de) 2002-07-31

Similar Documents

Publication Publication Date Title
IL168279A (en) Use of liposomal and aminoglycoside composition to prepare a drug for the treatment or improvement of infection
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
EP1367060A4 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
EP1364957A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
EP1364958A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
FI20115742L (fi) Mometasonifuroaatin käyttö lääkkeen valmistuksessa
EE200300226A (et) Lämmastikoksiidi inhaleerimine
DE60034476D1 (de) Topische nasenbehandlung mit desloratadin und mometason furoat
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
EP1207811A4 (de) Stickoxid-freisetzende medizinische artikel
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
HUP0303041A3 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU2003298551A8 (en) Nitric oxide and its biomedical significance
IL162850A0 (en) Nitric oxide donors for treatment of disease and injury
NO20022113D0 (no) Bruk av nitrogenoksid for behandling av sammensnöringer i luftveiene
AU2002348299A8 (en) Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
AU2003255111A8 (en) The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention
PL350128A1 (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application